Prof. Dan Peer scientific group developed genome editing system destroys cancer cells
Breakthrough treatment, with no side effects, may increase life expectancy in brain and ovarian cancer patients
Prof. Dan Peer, former CBRC Chair, and his scientific team from the Department of Cell Research and Immunology at the Shmunis School of Biomedicine and Cancer Research, have demonstrated that the CRISPR/Cas9 system is very effective in treating metastatic cancers, a significant step on the way to finding a cure for cancer.
The researchers developed a novel lipid nanoparticle-based delivery system that specifically targets cancer cells and destroys them by genetic manipulation. The system, called CRISPR-LNPs, carries a genetic messenger (messenger RNA), which encodes for the CRISPR enzyme Cas9 that acts as molecular scissors that cut the cells’ DNA.